BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Vaccines

ASCO 2025 Showcases New Oncology Paradigms, From Breast Cancer Breakthroughs to AI-Led Precision Medicine

The 2025 American Society of Clinical Oncology (ASCO) Annual Meeting wasn’t just another scientific gathering and it was a seismic event that redrew ...

June 06, 2025 | Report

Vietnam, VNVC Partner with Sanofi to Launch Local Vaccine Manufacturing and Boost Public Health Preparedness

Sanofi and the Vietnam Vaccine Company (VNVC) have officially launched a strategic collaboration focused on technology transfer for vaccine manufacturing. ...

May 28, 2025 | News

SK Bioscience Wins Supreme Court Patent Battle Against Pfizer Over Pneumococcal Vaccine

SK bioscience, a global innovative vaccine and biotech company committed to promoting human health from prevention to cure, announced that it the Supreme C...

May 22, 2025 | News

IDT Biologika Ramps Up Global CDMO Expansion Following SK Bioscience Acquisition

SK bioscience, a global innovative vaccine and biotech company committed to promoting human health from prevention to cure, announced that IDT Biologika, a...

May 21, 2025 | News

AIM Vaccine Secures PRC Clinical Approval for mRNA Shingles Vaccine, Strengthening Global Race in Next-Gen Immunization

While global giants like Moderna and BioNTech apply mRNA technology to broader disease markets, PRC's mRNA frontrunner is keeping pace. AIM Vaccine (06660....

May 20, 2025 | News

SK Bioscience to Lead Korea’s Avian Influenza Vaccine Development Under KRW 5.25B Pandemic Preparedness Program

SK bioscience, a global innovative vaccine and biotech company committed to promoting human health from prevention to cure, today announced that it has bee...

May 07, 2025 | News

Turn Therapeutics Achieves Breakthrough in Room-Temperature Vaccine Stability with 100% Live Virus Recovery

Turn Therapeutics, a clinical-stage pharmaceutical and medical device company, announced that it has achieved a critical milestone in its effort to r...

May 05, 2025 | News

Aptamer Group and University of Glasgow Partner to Advance Optimer-Based Vaccine Adjuvants for Swine Health

Aptamer Group plc (AIM: APTA), the leading developer of next-generation synthetic binders delivering innovation to the life science industry, has ente...

May 01, 2025 | News

SK Bioscience Wins Patent Case Against Moderna Clearing Path for Global mRNA Vaccine Development

SK bioscience, a global innovative vaccine and biotech company committed to promoting human health from prevention to cure, today announced that it has won...

April 24, 2025 | News

Docquity and AstraZeneca Strengthen Cancer and RSV Vaccine Support in Southeast Asia Through OAZisCare

OAZisCare, digitally powered by DocquityCare, has advanced patient education and adherence for cancer care and RSV vaccines since 2024 The collaboration...

April 23, 2025 | News

Singapore’s T Cell Diagnostics Licenses Duke-NUS Technology to Develop Rapid Point-of-Care T-Cell Assays

T Cell Diagnostics Pte. Ltd. ("TCD") has licensed an intellectual property (IP) and its related know-how from Duke-NUS Medical School to develop point-of-c...

April 18, 2025 | News

Thermo Fisher Launches 5L DynaDrive Single-Use Bioreactor to Accelerate Scalable Bioprocessing

Thermo Fisher Scientific Inc., the world leader in serving science, has introduced the 5L DynaDrive™ Single-Use Bioreactor (S.U.B.), designed to meet...

April 15, 2025 | News

GC Biopharma and KDCA Secure MFDS Approval for Korea’s First Recombinant Anthrax Vaccine, BARYTHRAX

GC Biopharma announced that the Korean Ministry of Food and Drug Safety (MFDS) has approved its anthrax vaccine, BARYTHRAX, jointly developed by...

April 10, 2025 | News

China’s AIM Vaccine Set to Launch World’s First Serum-Free Rabies Vaccine Following Regulatory Acceptance

AIM Vaccine Co., Ltd. (06660.HK), a leading PRC vaccine company, announced on April 7, 2025 that the company's research and development of the se...

April 08, 2025 | News

Stay Connected